International Journal of Cancer Management

Published by: Kowsar

Role of HDM2 Gene in Radio-Sensitivity of Esophageal Cancer Cell Lines to Irradiation

Mohsen Mohammadi 1 , * , Jalil Pirayesh Islamian 2 , Hadi Karami 3 , Maryam Oladghaffari 2 , Alireza Farajollahi 2 and Kazem Nejati-Koshki 4
Authors Information
1 Department of Medical Radiation Science, School of Paramedicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Department of Medical Physics, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
3 Department of Biotechnology, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran
4 Student Research Committee, Zanjan University of Medical Sciences, Zanjan, Iran
Article information
  • International Journal of Cancer Management: June 2017, 10 (6); e8950
  • Published Online: June 30, 2017
  • Article Type: Research Article
  • Received: September 13, 2016
  • Revised: April 15, 2017
  • Accepted: May 10, 2017
  • DOI: 10.5812/ijcm.8950

To Cite: Mohammadi M, Pirayesh Islamian J, Karami H, Oladghaffari M, Farajollahi A, et al. Role of HDM2 Gene in Radio-Sensitivity of Esophageal Cancer Cell Lines to Irradiation, Int J Cancer Manag. 2017 ; 10(6):e8950. doi: 10.5812/ijcm.8950.

Copyright © 2017, International Journal of Cancer Management. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Pirayesh Islamian J, Mohammadi M, Baradaran B, Farajollahi A, Aghamiri SM, Asghari Jafarabadi M, et al. Enhancing radiosensitivity of TE1, TE8, and TE 11 esophageal squamous carcinoma cell lines by Hdm2-siRNA targeted gene therapy in vitro. Bioimpacts. 2016; 6(2): 93-8[DOI][PubMed]
  • 2. Islamian JP, Mohammadi M, Baradaran B. Inhibition of human esophageal squamous cell carcinomas by targeted silencing of tumor enhancer genes: an overview. Cancer Biol Med. 2014; 11(2): 78-85[DOI][PubMed]
  • 3. Poynton AR, Walsh TN, Kelly A, Harney M, Stuart R, Daly PA. Small cell carcinoma of the oesophagus. Euro J Surgical Oncol. 1997; 23(6): 509-12
  • 4. Hagiwara N, Tajiri T, Tajiri T, Miyashita M, Sasajima K, Makino H, et al. Biological behavior of mucoepidermoid carcinoma of the esophagus. J Nippon Med Sch. 2003; 70(5): 401-7[PubMed]
  • 5. Bosset JF, Lorchel F, Mantion G. Neoadjuvant treatment of early stage squamous cell carcinoma of the esophagus. Dis Esophagus. 2002; 15(2): 117-20[PubMed]
  • 6. Xiao ZF, Yang ZY, Liang J, Miao YJ, Wang M, Yin WB, et al. Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg. 2003; 75(2): 331-6[PubMed]
  • 7. Medical Research Council Oesophageal Cancer Working G. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet. 2002; 359(9319): 1727-33[DOI][PubMed]
  • 8. Herskovic A, Martz K, al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992; 326(24): 1593-8[DOI][PubMed]
  • 9. Ogawa R, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Mori Y, et al. Identification of candidate genes involved in the radiosensitivity of esophageal cancer cells by microarray analysis. Dis Esophagus. 2008; 21(4): 288-97[DOI][PubMed]
  • 10. Lam AK. Molecular biology of esophageal squamous cell carcinoma. Crit Rev Oncol Hematol. 2000; 33(2): 71-90[PubMed]
  • 11. Mandard AM, Hainaut P, Hollstein M. Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat Res. 2000; 462(2-3): 335-42[PubMed]
  • 12. Futami T, Miyagishi M, Seki M, Taira K. Induction of apoptosis in HeLa cells with siRNA expression vector targeted against bcl-2. Nucleic Acids Res Suppl. 2002; (2): 251-2[PubMed]
  • 13. Nejati-Koshki K, Akbarzadeh A, Pourhasan-Moghaddam M, Abhari A, Dariushnejad H. Inhibition of leptin and leptin receptor gene expression by silibinin-curcumin combination. Asian Pac J Cancer Prev. 2014; 14(11): 6595-9[PubMed]
  • 14. Nasiri M, Zarghami N, Koshki KN, Mollazadeh M, Moghaddam MP, Yamchi MR, et al. Curcumin and silibinin inhibit telomerase expression in T47D human breast cancer cells. Asian Pac J Cancer Prev. 2013; 14(6): 3449-53[PubMed]
  • 15. Yuan Y, Liao YM, Hsueh CT, Mirshahidi HR. Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP. J Hematol Oncol. 2011; 4: 16[DOI][PubMed]
  • 16. Aghaee F, Pirayesh Islamian J, Baradaran B. Enhanced radiosensitivity and chemosensitivity of breast cancer cells by 2-deoxy-d-glucose in combination therapy. J Breast Cancer. 2012; 15(2): 141-7[DOI][PubMed]
  • 17. Teyssier F, Bay JO, Dionet C, Verrelle P. [Cell cycle regulation after exposure to ionizing radiation]. Bull Cancer. 1999; 86(4): 345-57[PubMed]
  • 18. Fekri Aval S, Akbarzadeh A, Yamchi MR, Zarghami F, Nejati-Koshki K, Zarghami N. Gene silencing effect of SiRNA-magnetic modified with biodegradable copolymer nanoparticles on hTERT gene expression in lung cancer cell line. Artif Cells Nanomed Biotechnol. 2016; 44(1): 188-93[DOI][PubMed]
  • 19. Wang XC, Wang W, Zhang ZB, Zhao J, Tan XG, Luo JC. Overexpression of miRNA-21 promotes radiation-resistance of non-small cell lung cancer. Radiat Oncol. 2013; 8: 146[DOI][PubMed]
  • 20. Zonouzi AAP, Nejatizadeh A, Rahmati-Yamchi M, Fardmanesh H, Shakerizadeh S, Zonouzi AP. Dysregulated expression of Dicer in invasive ductal breast carcinoma. Med Oncol. 2015; 32(7): 1-7
  • 21. Perry ME. Mdm2 in the response to radiation. Mol Cancer Res. 2004; 2(1): 9-19[PubMed]
  • 22. Cun Y, Dai N, Xiong C, Li M, Sui J, Qian C, et al. Silencing of APE1 enhances sensitivity of human hepatocellular carcinoma cells to radiotherapy in vitro and in a xenograft model. PLoS One. 2013; 8(2): 55313[DOI][PubMed]
  • 23. Duan W, Xu Y, Dong Y, Cao L, Tong J, Zhou X. Ectopic expression of miR-34a enhances radiosensitivity of non-small cell lung cancer cells, partly by suppressing the LyGDI signaling pathway. J Radiat Res. 2013; 54(4): 611-9[DOI][PubMed]
  • 24. Liu TG, Yin JQ, Shang BY, Min Z, He HW, Jiang JM, et al. Silencing of hdm2 oncogene by siRNA inhibits p53-dependent human breast cancer. Cancer Gene Ther. 2004; 11(11): 748-56[DOI][PubMed]
  • 25. Ozaki T, Nakagawara A. the attractive tumor suppressor in the cancer research field. BioMed Res Inter. 2010; : 53
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments